• DOI:10.1185/030079903125001875
Corpus ID: 20044143

Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitisof the scalp: an open-label,multicentre, prospective trial on180 patients

@article{Milani2003EfficacyOB,
  title={Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitisof the scalp: an open-label,multicentre, prospective trial on180 patients},
  author={M. Milani and S. Molfetta and Raffaele Gramazio and C. Fiorella and Costantino Frisario and Ernesto Fuzio and V. Marzocca and Maria Zurilli and G. Turi and G. Felice},
  journal={Current Medical Research and Opinion},
  year={2003},
  volume={19},
  pages={342 - 345}
}

M. Milani, S. Molfetta, +7 authors G. Felice

Published 2003

Medicine

Current Medical Research and Opinion

SUMMARY Background: Seborrhoeic dermatitis (SD) is a common chronic inflammatory disease of the skin. Topical steroid creams and/or antifungal agents are commonly used in SD, but no resolutive therapies have been available up to now. Furthermore, little data have been available regarding clinical outcomes after cessation of topical treatments. A new formulation of betamethasone valerate 0.1% in a thermophobic, low-residue, foam vehicle (Bettamousse *) (BVM) has become available for the topical… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed